Gulf Pharmaceutical Industries

JULPHARStocksAbu Dhabi Securities ExchangeHealthcare

Financials

1-5

	CurrentMar 10, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Market & Price
Market Capitalization	1.25B	1.35B	1.50B	1.52B	1.52B
Market Cap Growth	-21.7%	-10.0%	+49.9%	+61.0%	+38.8%
Enterprise Value	1.26B	1.38B	1.60B	1.64B	2.34B
Last Close Price	1.08	1.17	1.30	1.32	1.32
Valuation Multiples
PE Ratio	29.15	7.85	6.87	7.48	8.31
PS Ratio	1.16	1.26	1.45	1.49	1.50
PB Ratio	1.30	1.41	1.54	1.58	1.61
P/TBV Ratio	1.37	1.48	1.62	1.74	1.78
P/FCF Ratio	14.64	15.86	15.81	13.01	—
P/OCF Ratio	10.32	11.18	11.82	10.47	—
EV/Sales Ratio	1.18	1.28	1.54	1.60	2.30
EV/EBITDA Ratio	11.27	14.06	12.77	12.35	17.85
EV/EBIT Ratio	23.33	—	22.77	24.71	45.13
EV/FCF Ratio	14.84	16.21	16.80	14.00	—
Leverage & Capital
Debt / Equity Ratio	0.29	0.29	0.28	0.46	0.62
Debt / EBITDA Ratio	2.45	11.46	2.61	3.63	2.99
Debt / FCF Ratio	3.23	3.23	2.86	3.82	—
Net Debt / Equity Ratio	0.01	0.01	0.02	0.09	0.11
Net Debt / EBITDA Ratio	0.07	0.07	0.15	0.63	0.80
Net Debt / FCF Ratio	0.08	0.08	0.19	0.71	1.33
Efficiency & Liquidity
Asset Turnover	0.63	0.54	0.38	0.64	0.40
Inventory Turnover	1.48	1.96	1.36	0.83	2.01
Quick Ratio	1.62	1.62	1.72	2.07	2.13
Current Ratio	3.12	3.12	3.24	3.25	3.08
Returns & Yields
Return on Equity (ROE)	+3.0%	+2.2%	+4.1%	+9.9%	+0.3%
Return on Assets (ROA)	-0.5%	+1.2%	+1.9%	+3.8%	+1.2%
Return on Invested Capital (ROIC)	-0.4%	+0.8%	+1.2%	+2.3%	+0.1%
Return on Capital Employed (ROCE)	+4.2%	+4.2%	+5.3%	+4.5%	+3.4%
Earnings Yield	+13.8%	+12.7%	+14.6%	+13.4%	+12.0%
FCF Yield	+6.8%	+6.3%	+6.3%	+7.7%	+5.2%
Buyback Yield / Dilution	—	—	—	—	—
Total Shareholder Return	—	—	—	—	—

1-5

	CurrentMar 10, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Market & Price
Market Capitalization	1.25B	1.35B	1.50B	1.52B	1.52B
Market Cap Growth	-21.7%	-10.0%	+49.9%	+61.0%	+38.8%
Enterprise Value	1.26B	1.38B	1.60B	1.64B	2.34B
Last Close Price	1.08	1.17	1.30	1.32	1.32
Valuation Multiples
PE Ratio	29.15	7.85	6.87	7.48	8.31
PS Ratio	1.16	1.26	1.45	1.49	1.50
PB Ratio	1.30	1.41	1.54	1.58	1.61
P/TBV Ratio	1.37	1.48	1.62	1.74	1.78
P/FCF Ratio	14.64	15.86	15.81	13.01	—
P/OCF Ratio	10.32	11.18	11.82	10.47	—
EV/Sales Ratio	1.18	1.28	1.54	1.60	2.30
EV/EBITDA Ratio	11.27	14.06	12.77	12.35	17.85
EV/EBIT Ratio	23.33	—	22.77	24.71	45.13
EV/FCF Ratio	14.84	16.21	16.80	14.00	—
Leverage & Capital
Debt / Equity Ratio	0.29	0.29	0.28	0.46	0.62
Debt / EBITDA Ratio	2.45	11.46	2.61	3.63	2.99
Debt / FCF Ratio	3.23	3.23	2.86	3.82	—
Net Debt / Equity Ratio	0.01	0.01	0.02	0.09	0.11
Net Debt / EBITDA Ratio	0.07	0.07	0.15	0.63	0.80
Net Debt / FCF Ratio	0.08	0.08	0.19	0.71	1.33
Efficiency & Liquidity
Asset Turnover	0.63	0.54	0.38	0.64	0.40
Inventory Turnover	1.48	1.96	1.36	0.83	2.01
Quick Ratio	1.62	1.62	1.72	2.07	2.13
Current Ratio	3.12	3.12	3.24	3.25	3.08
Returns & Yields
Return on Equity (ROE)	+3.0%	+2.2%	+4.1%	+9.9%	+0.3%
Return on Assets (ROA)	-0.5%	+1.2%	+1.9%	+3.8%	+1.2%
Return on Invested Capital (ROIC)	-0.4%	+0.8%	+1.2%	+2.3%	+0.1%
Return on Capital Employed (ROCE)	+4.2%	+4.2%	+5.3%	+4.5%	+3.4%
Earnings Yield	+13.8%	+12.7%	+14.6%	+13.4%	+12.0%
FCF Yield	+6.8%	+6.3%	+6.3%	+7.7%	+5.2%
Buyback Yield / Dilution	—	—	—	—	—
Total Shareholder Return	—	—	—	—	—